GLAXO Pharmaceuticals: Major
Health Technology
Mkt Cap
110.3B
P/E (TTM)
10.75
EPS
31.48
ROE
31.52%
Div Yield
4.91%
About
GlaxoSmithKline Pakistan Ltd. is a healthcare company, which engages in the manufacturing and marketing research-based vaccines, medicines, and consumer healthcare products. It operates through the Pharmaceutical segment. The company was founded in 1947 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 65.90B | 61.19B | 49.66B | 41.84B | 36.66B | |
| Gross Profit | 22.94B | 14.46B | 3.06B | 6.92B | 9.33B | |
| Net Income | 10.03B | 6.54B | 533.95M | 2.46B | 5.35B | |
| EPS | 31.48 | 20.52 | 1.68 | 7.73 | 16.81 | |
| ROE | 32.37% | 26.17% | 2.50% | 11.72% | 27.84% | |
| ROA | 20.61% | 15.48% | 1.44% | 7.46% | 18.94% | |
| Gross Margin | 34.81% | 23.63% | 6.15% | 16.53% | 25.45% | |
| Net Margin | 15.21% | 10.68% | 1.08% | 5.89% | 14.61% | |
| Current Ratio | 2.32 | 2.06 | 1.74 | 1.82 | 2.28 | |
| DPS | 17.00 | 10.00 | 0.00 | 0.00 | 7.00 | |
| Free Cash Flow | 6.60B | 2.82B | 514.01M | -3.87B | 4.06B |